AC
Armistice Capital Portfolio holdings
AUM
$3.19B
1-Year Est. Return
7.19%
1 Year Est. Return
+7.19%
AUM
$3.19B
AUM Growth
+$548M
(+21%)
Holding
386
Top Buys
| 1 | +$66.4M | |
| 2 | +$40.8M | |
| 3 | +$36.9M | |
| 4 |
Starbucks
SBUX
|
+$30.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
Top Sells
| 1 | +$94.4M | |
| 2 | +$89.5M | |
| 3 | +$51.4M | |
| 4 |
Grifois
GRFS
|
+$50.4M |
| 5 |
STAAR Surgical
STAA
|
+$47.2M |
Sector Composition
| 1 | Healthcare | 67.5% |
| 2 | Technology | 11.75% |
| 3 | Consumer Discretionary | 11.16% |
| 4 | Communication Services | 4.26% |
| 5 | Consumer Staples | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agios Pharmaceuticals
AGIO
$1.6B
| $30.7M | 0.45% |
764,000
-404,000
|
|
||
|
27
Starbucks
SBUX
$96.9B
| $30.1M | 0.45% |
+356,107
|
|
||
28
Immunocore
IMCR
$1.98B
| $29.9M | 0.44% |
824,000
+146,000
|
|
||
|
29
Bristol-Myers Squibb
BMY
$105B
| $29.3M | 0.43% |
+649,733
|
|
||
30
Avanos Medical
AVNS
$517M
| $28.9M | 0.43% |
2,500,000
+464,000
|
|
||
31
Sanofi
SNY
$120B
| $28.9M | 0.43% |
+612,000
|
|
||
32
Disc Medicine
IRON
$3.51B
| $28.8M | 0.43% |
436,000
|
|
||
33
Datadog
DDOG
$53.7B
| $28.8M | 0.43% |
202,061
+52,061
|
|
||
34
Alibaba
BABA
$375B
| $27.9M | 0.41% |
156,000
+98,000
|
|
||
35
Thermo Fisher Scientific
TMO
$215B
| $26.7M | 0.4% |
55,016
+25,052
|
|
||
|
AUTL
36
Autolus Therapeutics
AUTL
$418M
| $25.4M | 0.38% |
15,600,000
+3,600,000
|
|
||
37
Medtronic
MDT
$131B
| $25.3M | 0.37% |
265,257
+1,257
|
|
||
|
NBIS
38
Nebius Group N.V.
NBIS
$25.5B
| $23.9M | 0.36% |
213,280
+89,280
|
|
||
|
BCYC
39
Bicycle Therapeutics
BCYC
$499M
| $23M | 0.34% |
2,978,000
+178,000
|
|
||
|
40
Grifois
GRFS
$6.05B
| $22.3M | 0.33% |
2,236,000
-5,062,000
|
|
||
41
CVS Health
CVS
$96B
| $22M | 0.33% |
+291,819
|
|
||
42
Axogen
AXGN
$1.55B
| $21.4M | 0.32% |
1,200,000
+88,681
|
|
||
43
Ironwood Pharmaceuticals
IRWD
$582M
| $21.2M | 0.31% |
16,150,000
|
|
||
44
HubSpot
HUBS
$19.7B
| $21.1M | 0.31% |
45,018
+22,914
|
|
||
45
Rigel Pharmaceuticals
RIGL
$857M
| $20.5M | 0.3% |
724,000
-876,000
|
|
||
46
Voyager Therapeutics
VYGR
$242M
| $19.6M | 0.29% |
4,200,000
-600,000
|
|
||
47
SentinelOne
S
$5.74B
| $19.6M | 0.29% |
1,111,200
-124,284
|
|
||
48
Dynatrace
DT
$13.4B
| $19.4M | 0.29% |
400,000
+176,012
|
|
||
49
Mineralys Therapeutics
MLYS
$3.13B
| $19.3M | 0.29% |
507,650
+329,650
|
|
||
50
Verastem
VSTM
$780M
| $18.5M | 0.27% |
2,096,000
-40,000
|
|